Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.

Research output: Contribution to journalArticle

Abstract

To evaluate whether the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant might be effective for migraine prevention.

Details

Authors
  • Tony W Ho
  • Kathryn M Connor
  • Ying Zhang
  • Eric Pearlman
  • Janelle Koppenhaver
  • Xiaoyin Fan
  • Christopher Lines
  • Lars Edvinsson
  • Peter J Goadsby
  • David Michelson
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
Pages (from-to)958-966
JournalNeurology
Volume83
Issue number11
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes